Do you want BuboFlash to help you learning these things? Or do you want to add or correct something? Click here to log in or create user.



Bowen’s disease (squamous cell carcinoma in situ, 18.10): pale keratinocytes may be present which contain glycogen (PAS positive, diastase labile) with frequent dyskeratosis (1.27). Full-thickness atypia often involves basal cells also. High molecular weight keratin positive. Mucin stains, CEA, EMA, CK-7, CK-8 and low molecular weight keratin negative. However, cases have been published with exceptions, such as positive staining for CK-7 and EMA. Usually no pagetoid cells in the stratum corneum, which sometimes occurs with Paget’s disease and melanoma
If you want to change selection, open original toplevel document below and click on "Move attachment"

Parent (intermediate) annotation

Open it
positive. Mucin in cytoplasm is often positive with mucicarmine, Alcian blue, colloidal iron, and PAS with and without diastase. Basal cells are often compressed and uninvolved. No dyskeratosis <span>Bowen’s disease (squamous cell carcinoma in situ, 18.10): pale keratinocytes may be present which contain glycogen (PAS positive, diastase labile) with frequent dyskeratosis (1.27). Full-thickness atypia often involves basal cells also. High molecular weight keratin positive. Mucin stains, CEA, EMA, CK-7, CK-8 and low molecular weight keratin negative. However, cases have been published with exceptions, such as positive staining for CK-7 and EMA. Usually no pagetoid cells in the stratum corneum, which sometimes occurs with Paget’s disease and melanoma Borst–Jadassohn phenomenon: discrete clones of basaloid, squamatized, or pale keratinocytes in the epidermis that appear different than their neighbors. This can be benign or malignant.

Original toplevel document (pdf)

owner: gss4 - (no access) - book_Practical-Dermatopathology.pdf, p23


Summary

statusnot read reprioritisations
last reprioritisation on suggested re-reading day
started reading on finished reading on

Details



Discussion

Do you want to join discussion? Click here to log in or create user.